Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome

38Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Metabolic syndrome (MetS) is a complex metabolic disease connected especially with lipid and carbohydrate disturbances. It is postulated that oxidative stress (OS) is linked to metabolic syndrome, constituting a novel component of its pathogenesis. Aim: We aimed to examine the plasma level of oxidatively modified proteins-advanced oxidation protein products (AOPP) and ischemia modified albumin (IMA)-as well as thiol (SH) groups and evaluate their connection with metabolic agents in relation to MetS prevalence. Subjects and methods The levels of AOPP, IMA and SH groups were measured spectrophotometrically in 106 patients with MetS risk factors and in 32 control subjects. Results: The levels of examined parameters differed significantly between patients with MetS risk factors and the control group. AOPP significantly correlated with glucose (r = 0.30, p = 0.008), HDL-Ch (r = -0.34, p = 0.005), TG (r = 0.48, p<0.001) and fibrinogen (r = 0.37, p<0.001). The levels of AOPP and IMA increased progressively with the number of MetS risk factors, being the most significant for AOPP. The highest values of AOPP were associated with the presence of at least three risk factors. Only AOPP were an independent determinant for MetS occurrence in the studied population (OR = 2.72, p = 0.04). Mutual dependence between metabolic, oxidative stress and inflammatory parameters was revealed. Conclusions: Oxidative modifications of proteins are increased in MetS and accumulation of MetS risk factors enhances manifestation of OS. AOPP is the most appropriate parameter for determination of OS, with potential diagnostic value in MetS patients.

Cite

CITATION STYLE

APA

Żurawska-Płaksej, E., Grzebyk, E., Marciniak, D., Szymańska-Chabowska, A., & Piwowar, A. (2014). Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome. Journal of Endocrinological Investigation, 37(9), 819–827. https://doi.org/10.1007/s40618-014-0111-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free